Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2072-003) of SYH2072 tablets (this product) developed by the Group for the treatment of uncontrolled and refractory hypertension (SYH2072-003) has been officially launched at the first research center in China.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2072-003) of SYH2072 tablets (this product) developed by the Group for the treatment of uncontrolled and refractory hypertension (SYH2072-003) has been officially launched at the first research center in China.